The Cyprus Foundation For Muscular Dystrophy Research — Clinical Trial Site

7 Registered trials

3 Currently recruiting

Organisation

The Cyprus Foundation For Muscular Dystrophy Research

Location

Agios Dometios, Cyprus

Identifier

ORG-100040915

Address

Iroon Avenue 6, 2371, Cyprus

Departments

N/A
Neuroepidemiology Department
Neuroepidemiology Department and EMG (Electromyography) Laboratory
Neuromuscular Disorders Centre
Neuroscience Department
Neuroscience Department, Neuromuscular Disorders Center,

Clinical trials at this site (7)

Search interface

TRITON-PN: A Phase 3 Study to Evaluate the Efficacy and Safety of Nucresiran in Patients with Hereditary Transthyretin Amyloidosis with Poly… Recruiting

2025-522544-40-00 Hereditary transthyretin-mediated amyloidosis with poly 5 2026-03-27
A study to assess the long-term safety and efficacy of a subcutaneous formulation of efgartigimod in adults with active idiopathic inflammat… Recruiting

2022-502851-79-00 Active Idiopathic Inflammatory Myopathy (IIM) 5 2023-09-20
Study to Assess the Long-Term Safety and Efficacy of ION-682884 in Patients with Hereditary Transthyretin-Mediated Amyloid Polyneuropathy Recruiting

2024-511201-32-00 Hereditary Transthyretin-Mediated Amyloid Polyneuropath 5 2022-06-13
A study to assess efficacy and safety of efgartigimod PH20 SC in adults with ocular myasthenia gravis Ended

2024-514133-38-00 Ocular Myasthenia Gravis 5 2025-03-19
A Phase 3 study to evaluate the Efficacy and Safety of Efgartigimod IV in Patients with Acetylcholine Receptor Binding Antibody Seronegative… Ended

2024-511796-15-00 Acetylcholine Receptor Binding Antibody Seronegative Ge 5 2024-10-16
A study to investigate the efficacy and safety of efgartigimod PH20 SC in adult participants with active idiopathic inflammatory myopathy Ended

2024-512785-33-00 Active Idiopathic Inflammatory Myopathy (IIM) 10 2023-03-01
HELIOS-A: A Phase 3 Global Study to Evaluate the Efficacy and Safety of ALN-TTRSC02 in Patients with Hereditary Transthyretin Amyloidosis Ended

2023-508365-33-00 Hereditary Transthyretin Amyloidosis 5 2019-04-09